Skip to main content
. 2017 Feb 23;15(2):e04694. doi: 10.2903/j.efsa.2017.4694

Figure 45.

Figure 45

Trends in ciprofloxacin, erythromycin and tetracycline resistance in Campylobacter jejuni from humans in reporting countries, 2013–2015

  • Statistically significant increasing trends over 3 years, as tested by logistic regression (p ≤ 0.05), were observed for ciprofloxacin in Austria, Estonia, France, the Netherlands and Slovakia (↑), for erythromycin in Slovakia (↑) and for tetracycline in Austria, Estonia, Italy, the Netherlands and Slovakia (↑). Statistically significant decreasing trends over 3 years were observed for erythromycin in Luxembourg and Malta (↓). Only countries testing at least 10 isolates per year were included in the analysis.